Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis

<b>Background</b>: Edoxaban is a novel oral anticoagulant which may decrease the risk of stroke and systemic embolism in patients suffering from atrial fibrillation (AF). However, the decreased efficacy of edoxaban versus warfarin for the avoidance of stroke and systemic embolism in AF w...

Full description

Bibliographic Details
Main Authors: Yapeng Wang, Li Li, Zhanlan Wei, Shan Lu, Wenxue Liu, Janghui Zhang, Junbo Feng, Dongjin Wang
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Medicines
Subjects:
Online Access:https://www.mdpi.com/2305-6320/10/1/13